menu search

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f

SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...

April 16, 2023, 5:00 pm

7 stocks to sell in april before they crash and burn

The markets may be showing solid signs of improvement, but there are still many stocks to sell. In fact, in this environment of elevated interest rat...

April 16, 2023, 3:31 pm

Small business association to close disaster loan outreach center in san luis obispo

The U.S. Small Business Association announced that it will be closing its Disaster Loan Outreach Center on April 18. Read Full Story at source (may re...

April 16, 2023, 3:14 pm

Forex and cryptocurrency forecast

EUR/USD: The Dollar Continues to Sink The DXY dollar index updated a 12-month low last week, and EUR/USD, respectively, rose to a maximum (1.1075) sin...

April 16, 2023, 1:35 pm

Evergent announces its flagship evergent monetization platform will now be available on google cloud marketplace

Organizations can now access this flexible customer management and monetization platform running on Google Cloud SUNNYVALE, Calif., April 16, 2023 (GL...

April 16, 2023, 12:45 pm

Video shows new mexico police were at wrong house seconds before killing homeowner

By Joseph Ax (Reuters) – New Mexico police officers realized they were at the wrong address just moments before the front door opened and they fatal...

April 16, 2023, 10:50 am

2 high-growth cybersecurity stocks to buy in april 2023

Cybersecurity services have become essential for the smooth and secure functioning of businesses. Zscaler's zero trust technology continues to be in h...

April 16, 2023, 10:15 am

Uber denies accusations of charging fares based on phone battery levels

This segment originally aired on April 14, 2023 Yahoo Finance's Pras Subramanian discusses reports that Uber is being accused of scaling fares based o...

April 16, 2023, 10:00 am

Ferrari boasts record orders of 296 plug-in hybrid at shareholders meeting

This segment originally aired on April 14, 2023. Yahoo Finance automotive reporter Pras Subramanian joins the Live show to discuss the key takeaways f...

April 16, 2023, 10:00 am


Search within

Pages Search Results: